Summary
- Revenue
- GLPG current annual revenue is $1.26B, up +320.99% year-over-year
- Next Earnings
- As of today, the next earnings release for GLPG has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Lakefront Biotherapeutics NV |
| Ticker | NASDAQ: GLPG |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Belgium |
| IPO | |
| Indexes | Not included |
| Website | glpg.com |
| Employees | 704 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | - | |
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| - | N/A | |
| $1.26B | ||
| Revenue, 1Y Change | +320.99% | |
| $5.50 | ||
| EPS, 1Y Change | +351.91% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $5.50 | ||
| EPS Estimate | -$6.22 | N/A |
| EPS Est. Change | -213.25% | N/A |
| $1.26B | ||
| Revenue Estimate | $271.90M | N/A |
| Revenue Est. Change | -78.34% | N/A |
| Current Price | - | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.35 | $1.22 | +244.18% | |
| -$3.75 | $5.50 | +246.54% | |
| -$6.22 | N/A | -213.25% | |
| -$1.37 | N/A | -124.84% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $288.22M | $298.17M | +3.45% | |
| $280.01M | $1.26B | +348.29% | |
| $271.90M | N/A | -78.34% | |
| $162.44M | N/A | -87.06% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | - | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $1.26B | ||
| $5.50 | ||
| $1.22B | ||
| 92.66% | ||
| $530.05M | ||
| 42.23% | ||
| $360.57M | ||
| 28.72% | ||
| $588.57M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 20.15 | ||
| 20.00 | ||
| - | ||
| 7 | ||
| - |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $3.80B | ||
| $3.52B | ||
| $4.00B | ||
| $3.62B | ||
| $200.42M | ||
| $179.53M | ||
| $8.12M | ||
| $2.03M | ||
| $122.90M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $894.69M | ||
| $691.65M | ||
| $92.08M | ||
| $0.00 | ||
| $63.06M | ||
| $0.00 | ||
| -$21.02M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$222.34M | ||
| $257.73M | ||
| -$3.69M | ||
| $15.64M | ||
| -$237.98M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| RBC Capital | → | |
| RBC Capital | → | |
| RBC Capital | → | |
| Leerink Partners | → | |
| Morgan Stanley | → | |
| Barclays | → | |
| RBC Capital | → | |
| Leerink Partners | ||
| Morgan Stanley | → | |
| B of A Securities | → |
Analyst sentiment
Institutional ownership
Screeners with GLPG
FAQ
- What is the ticker symbol for Lakefront Biotherapeutics NV?
- The ticker symbol for Lakefront Biotherapeutics NV is NASDAQ:GLPG
- Does Lakefront Biotherapeutics NV pay dividends?
- No, Lakefront Biotherapeutics NV does not pay dividends
- What sector is Lakefront Biotherapeutics NV in?
- Lakefront Biotherapeutics NV is in the Healthcare sector
- What industry is Lakefront Biotherapeutics NV in?
- Lakefront Biotherapeutics NV is in the Biotechnology industry
- What country is Lakefront Biotherapeutics NV based in?
- Lakefront Biotherapeutics NV is headquartered in Belgium
- When did Lakefront Biotherapeutics NV go public?
- Lakefront Biotherapeutics NV initial public offering (IPO) was on February 27, 2012
- Is Lakefront Biotherapeutics NV in the S&P 500?
- No, Lakefront Biotherapeutics NV is not included in the S&P 500 index
- Is Lakefront Biotherapeutics NV in the NASDAQ 100?
- No, Lakefront Biotherapeutics NV is not included in the NASDAQ 100 index
- Is Lakefront Biotherapeutics NV in the Dow Jones?
- No, Lakefront Biotherapeutics NV is not included in the Dow Jones index
- When was Lakefront Biotherapeutics NV last earnings report?
- Lakefront Biotherapeutics NV's most recent earnings report was on May 6, 2026
- When does Lakefront Biotherapeutics NV report earnings?
- The date for Lakefront Biotherapeutics NV's next earnings report has not been announced yet
Data Sources & References
- GLPG Official Website www.glpg.com
- GLPG Profile on Yahoo Finance finance.yahoo.com/quote/GLPG
- GLPG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/glpg